US FDA announced plans to update the safety label for paracetamol to reflect studies suggesting a possible association between prenatal use and neurodevelopmental conditions. Research pointed towards a link between acetaminophen use during pregnancy and an increased risk of neurodevelopmental disorders, but scientists caution that a direct cause-and-effect relationship has not been established.